Markus Schirle Selected Research

Skin Ulcer

1/2021

BET bromodomain inhibitors regulate keratinocyte plasticity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Schirle Research Topics

Disease

15	Neoplasms (Cancer) 10/2022 - 10/2002
2	Breast Neoplasms (Breast Cancer) 11/2020 - 01/2019
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2020 - 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 10/2022
1	Cystic Fibrosis (Mucoviscidosis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Skin Ulcer 01/2021
1	Leukemia 01/2020
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2019
1	Hypersensitivity (Allergy) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Infections 11/2015
1	Malaria 11/2015
1	Starvation 11/2014
1	Intellectual Disability (Idiocy) 10/2014
1	Multiple Myeloma 08/2014
1	Staphylococcal Infections 11/2013
1	Hepatitis C 02/2010
1	Inflammation (Inflammations) 10/2008
1	Necrosis 02/2004
1	Pathologic Processes 02/2004
1	Melanoma (Melanoma, Malignant) 05/2002

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 10/2022 - 05/2002
3	Pharmaceutical PreparationsIBA 01/2022 - 11/2015
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2020 - 10/2014
2	RNA Precursors (Precursor, mRNA)IBA 01/2020 - 01/2020
2	nimbolideIBA 01/2020 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 02/2004
2	Biological ProductsIBA 01/2019 - 01/2019
2	LigandsIBA 12/2002 - 10/2002
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2002 - 10/2002
1	Adenosine Triphosphatases (ATPase)IBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Annexin A5IBA 10/2022
1	Chloride Channels (Chloride Channel)IBA 01/2022
1	lumacaftorIBA 01/2022
1	manumycinIBA 11/2020
1	PolyketidesIBA 11/2020
1	JTE 607IBA 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	snake venom protein C activatorIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2019
1	Complement C5 (Complement 5)IBA 01/2019
1	Bromodomain Containing ProteinsIBA 01/2019
1	eculizumab FDA Link 01/2019
1	Terpenes (Terpenoids)IBA 01/2019
1	LignansIBA 01/2019
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016
1	TankyrasesIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	AngiomotinsIBA 01/2016
1	Peptide Elongation Factor 1 (EF-1)IBA 08/2015
1	Ferritins (Ferritin)IBA 11/2014
1	IronIBA 11/2014
1	Thalidomide (Thalomid)FDA Link 08/2014
1	pomalidomideIBA 08/2014
1	Lenalidomide (CC 5013)FDA Link 08/2014
1	Immunomodulating AgentsIBA 08/2014
1	OSW 1IBA 08/2011
1	Carrier Proteins (Binding Protein)IBA 08/2011
1	cephalostatin IIBA 08/2011
1	schweinfurthin AIBA 08/2011
1	oxysterol binding proteinIBA 08/2011
1	ritterazine BIBA 08/2011
1	OxysterolsIBA 08/2011
1	CateninsIBA 05/2011
1	(melle-4)cyclosporinIBA 02/2010
1	Cyclophilins (Cyclophilin)IBA 02/2010
1	Tyrosine (L-Tyrosine)FDA Link 10/2008
1	NF-kappa B (NF-kB)IBA 02/2004
1	CytokinesIBA 02/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2004
1	AntigensIBA 05/2002
1	Monophenol Monooxygenase (Tyrosinase)IBA 05/2002
1	HLA-A*02:01 antigenIBA 05/2002
1	EpitopesIBA 05/2002
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2002

Therapy/Procedure

6	Therapeutics 10/2022 - 10/2009